A US payer perspective health economic model assessing value of monitoring disease activity to inform discontinuation and re-initiation of DMT in multiple sclerosisKian Jalaleddini, Mike Edgeworth, Shannon R. McCurdy et al.|Multiple Sclerosis Journal|2024Cited by 2